FDA Inspection 1256136 — Vitalant
The FDA completed an inspection of Vitalant on Nov 14, 2024 in Spokane, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 14, 2024
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Spokane, WA (United States)